Cabatuan Nelson 4
4 · RIGEL PHARMACEUTICALS INC · Filed Oct 16, 2018
Insider Transaction Report
Form 4
Cabatuan Nelson
Principal Accounting Officer
Transactions
- Sale
Common Stock
2018-10-12$3.12/sh−10,000$31,200→ 58 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 5, 2018.
- [F2]Includes Reporting Person's purchases of 5,000 shares on December 29, 2017 and 5,000 shares on June 26, 2018 under the Issuer's Employee Stock Purchase Plan.